» Articles » PMID: 9007060

Complementation of Deletion of the Vaccinia Virus E3L Gene by the Escherichia Coli RNase III Gene

Overview
Journal Virology
Specialty Microbiology
Date 1997 Jan 6
PMID 9007060
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

This work investigated whether the Escherichia coli RNase III gene, rnc+, could complement vp1080, a mutant vaccinia virus that is deleted of its E3L gene. Like E3L, rnc+ codes for a dsRNA binding protein that contains an additional nucleolytic activity. Rnc genes were cloned into the eukaryotic expression vector pMTVa-, expressed in COS-1 cells, and shown to be functional. Transient rescue experiments in HeLa cells demonstrated that the cleavage function of the rnc+ gene was necessary for full rescue of vp1080. The rnc 70 gene, which encodes a product deficient in catalytic activity but still capable of binding to dsRNA, rescued vp1080 weakly. The rnc 105 gene, which encodes a product that cannot bind or cleave dsRNA, was unable to rescue vp1080. The rnc genes were also inserted into the E3L locus of vp1080. While recombinants containing the rnc+ gene or the rnc 70 gene regained the IFN resistance phenotype in RK13 cells, full host range of vaccinia virus was only restored in the recombinant containing the rnc+ gene. Thus, the ability of RNase III to process dsRNA appears to be necessary to restore the host range phenotype. The vp-rnc 105 recombinant behaved similarly to vp1080.

Citing Articles

Identification of Orbivirus Non-Structural Protein 5 (NS5), Its Role and Interaction with RNA/DNA in Infected Cells.

Mohd Jaafar F, Monsion B, Mertens P, Attoui H Int J Mol Sci. 2023; 24(7).

PMID: 37047816 PMC: 10095184. DOI: 10.3390/ijms24076845.


Intranasal Immunization with a Vaccinia Virus Vaccine Vector Expressing Pre-Fusion Stabilized SARS-CoV-2 Spike Fully Protected Mice against Lethal Challenge with the Heavily Mutated Mouse-Adapted SARS2-N501Y Strain of SARS-CoV-2.

Kibler K, Szczerba M, Lake D, Roeder A, Rahman M, Hogue B Vaccines (Basel). 2022; 10(8).

PMID: 35893821 PMC: 9394475. DOI: 10.3390/vaccines10081172.


Antagonism of Protein Kinase R by Large DNA Viruses.

Olson A, Child S, Geballe A Pathogens. 2022; 11(7).

PMID: 35890034 PMC: 9319463. DOI: 10.3390/pathogens11070790.


Intranasal immunization with a vaccinia virus vaccine vector expressing pre-fusion stabilized SARS-CoV-2 spike fully protected mice against lethal challenge with the heavily mutated mouse-adapted SARS2-N501Y strain of SARS-CoV-2.

Kibler K, Szczerba M, Lake D, Roeder A, Rahman M, Hogue B bioRxiv. 2021; .

PMID: 34909775 PMC: 8669842. DOI: 10.1101/2021.12.06.471483.


Myxoma Virus-Encoded Host Range Protein M029: A Multifunctional Antagonist Targeting Multiple Host Antiviral and Innate Immune Pathways.

Rahman M, McFadden G Vaccines (Basel). 2020; 8(2).

PMID: 32456120 PMC: 7349962. DOI: 10.3390/vaccines8020244.